Kalvista Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$27.00

+0.01 (+0.04%)

As of Aug 1, 1:47 AM ET ·

Analyst Consensus

Hold

Analysts

Moderate

Coverage

Buy 7 54%

Hold 6 46%

Sell 0 0%

Price Target

Analyst Price Target +139.9% upside

Low Target $35.35

Average Target $64.76

High Target $75.74

Current Price $27.00

Current
$27.00

Target
$64.76

$35.35 $64.76 avg $75.74

Scenario Analysis

Bear Case

$35.35

30.9%

Low target

Base Case

$64.76

+139.9%

Avg target

Bull Case

$75.74

+180.5%

High target

Risk/Reward

5.8x

Highly favorable

Price in Context

52-Week High

$27.00

0.0% from high

52-Week Low

$10.41

+159.4% from low

Target vs 52W High

$64.76

+139.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%